MCF Advisors LLC Has $54,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

MCF Advisors LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 54.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 589 shares of the company’s stock after selling 703 shares during the period. MCF Advisors LLC’s holdings in GE HealthCare Technologies were worth $54,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 2.8% during the 4th quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock worth $3,969,975,000 after purchasing an additional 1,401,566 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of GE HealthCare Technologies by 14.7% during the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after buying an additional 5,693,244 shares during the last quarter. Hotchkis & Wiley Capital Management LLC lifted its holdings in GE HealthCare Technologies by 9.4% in the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock valued at $426,186,000 after buying an additional 471,910 shares during the period. Dimensional Fund Advisors LP boosted its stake in GE HealthCare Technologies by 17.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,454,690 shares of the company’s stock valued at $267,121,000 after acquiring an additional 504,287 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $229,052,000. Institutional investors own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In related news, insider Frank R. Jimenez acquired 1,315 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares in the company, valued at $5,799,909.92. The purchase was disclosed in a filing with the SEC, which is available at this link. In other news, insider Frank R. Jimenez bought 1,315 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The shares were bought at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jan Makela sold 20,227 shares of GE HealthCare Technologies stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the sale, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at $5,167,296.36. The disclosure for this sale can be found here. Insiders sold 90,482 shares of company stock valued at $7,369,137 in the last quarter. 0.27% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on GEHC shares. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Mizuho cut their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. Evercore ISI increased their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. The Goldman Sachs Group started coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price on the stock. Finally, Argus raised their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $94.09.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $77.92 on Friday. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. The firm has a 50-day moving average of $79.85 and a 200-day moving average of $81.80. The company has a market cap of $35.57 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 2.80 and a beta of 1.22. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting analysts’ consensus estimates of $0.90. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. GE HealthCare Technologies’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company posted $0.85 earnings per share. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.